Ginsenoside Re Improves Inflammation and Fibrosis in Hepatic Tissue by Upregulating PPARγ Expression and Inhibiting Oxidative Stress in db/db Mice

Ginsenoside Re (Re) is the main component of “Zhenyuan Capsule” (ZYC), which was wildly used in clinic in China for adjunctive treatment of coronary heart disease (CHD) and type II diabetes (T2DM). Nonalcoholic fatty liver disease (NAFLD) is one of the most important complications of T2DM, as well a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yichuan, Sui, Dayun, Li, Min, Xu, Huali, Yu, Xiaofeng, Liu, Jinsha, Yu, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519719/
https://www.ncbi.nlm.nih.gov/pubmed/34659439
http://dx.doi.org/10.1155/2021/9003603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519719/
https://www.ncbi.nlm.nih.gov/pubmed/34659439
http://dx.doi.org/10.1155/2021/9003603

Ejemplares similares